Effects of a novel ascorbate-based protocol on infarct size and ventricle function in acute myocardial infarction patients undergoing percutaneous coronary angioplasty
Timing Follow-up Marker Blood pressure and resting heart rate Why it matters Adds cardiovascular context during weight loss, medication changes, and hydration shifts
Myth: If I have side effects, I should just stop the medication. Fact: Most side effects can be managed by slowing down the titration schedule or making small lifestyle adjustments
Results from the clinical trials: SURPASS-1: A Phase 3 clinical trial that included more than 4,500 patients with diabetes and inadequately controlled glycemia
If side effects remain intolerable, your healthcare provider may recommend staying at a lower dose longer, switching to oral semaglutide, or exploring alternative medications
Similar to previously approved GLP-1RAs, weight loss is a common side effect of Tirzepatide which prompted research focused on its use as a primary weight loss therapy